VIVIMEDLAB — Vivimed Labs Share News
0.000.00%
- IN₹504.95m
- IN₹4.40bn
- IN₹699.89m
Brief: Vivimed Labs Says Strides Vivimed JV Receives U.S. FDA Approval For Albendazole Tablets
Brief: India's Vivimed Labs Sept-Qtr Consol Profit Falls
Brief: Vivimed Labs Says API Manufacturing Facility In Mexico Recently Inspected By FDA
Brief: India's Vivimed Labs June-Qtr Profit Rises
Brief: Vivimed Labs Announces Acquisition Of SONEAS By Group's API Business
Brief: Vivimed Labs Seeks Shareholders' Nod For Issue Of Convertible Warrants To Promoters
Brief: Vivimed Labs To Consider Raising Capital
Brief: Strides Shasun To Launch Ranitidine OTC Tablets In U.S.
Brief: India's Vivimed Labs Signs Distribution Agreement With Alter Ego LLC
Brief: Vivimed Labs Announces Additional Investment By Orbimed Asia
Brief: Vivimed Labs says FDF facility gets GMP certification by Ukraine ministry of health
Brief: Vivimed Labs seeks members' nod for issue of convertible warrants
Brief: Vivimed Labs appoints Ramesh Challa as CFO
Brief: Vivimed Labs appoints Pavan Kumar as CEO
Brief: Vivimed Labs gets CCI approval for acquisition of certain products in its speciality chemicals unit by Clariant India
Brief: Vivimed Labs Sept-qtr consol profit rises